Skip to main content

Weather alert

Due to Hurricane Isaias, our Patient Service Centers in affected areas may be closed. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational. For site-specific information, please use Find a location and enter your zip code.

Hide
Quest Diagnostics

Distinct Rates of VUS Reclassification Are Observed When Subclassifying VUS by Evidence Level

Distinct Rates of VUS Reclassification Are Observed When Subclassifying VUS by Evidence Level

Authors: Bennett G, Karbassi I, Chen W, Harrison SM, Lebo MS, Meng L, Nagan N, Rigobello R, Rehm HL

Citation: Genet Med. 2025 Feb 28:101400. doi: 10.1016/j.gim.2025.101400. Online ahead of print.

Specialties: Genetics

Related content

Publication
The landscape of reported VUS in multi-gene panel and genomic testing: time for a change
Conference Presentation
Reclassifying Promising Variants of Uncertain Significance (VUSs) Using a Proactive VUS Clarification Service
Conference Presentation
Genetic Testing and the Vision of Precision Medicine

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.